跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26,734 条关于
“homologous recombination repair genes”
全部
26,734
临床试验
21,184
药物
1,347
机构
56
资讯
4,147
去年
LODESTAR Study Marks First Tumor-Agnostic Trial of PARP Inhibitor Rucaparib in HRR Gene Variants
去年
STAMPEDE2 Trial to Evaluate Niraparib and Abiraterone Combination in Metastatic Hormone-Sensitive Prostate Cancer
2年前
Neoadjuvant Chemohormonal Therapy Shows Promise for High-Risk Prostate Cancer
去年
Genomic Scarring Score Predicts PARP Inhibitor Response in NSCLC
2年前
Eisai's E7820 Shows Promise in Shrinking Tumors with HRR Deficiency
去年
Eisbach Bio Relocates to Houston with $4.75M CPRIT Grant to Advance EIS-12656 Trial in HRD Tumors
去年
ctDNA Analysis Reveals Mechanisms of PARP Inhibitor Resistance in Prostate Cancer
去年
AMPLITUDE Trial Shows Niraparib Combination Reduces Cancer Progression Risk by 37% in HRR-Mutant Metastatic Prostate Cancer
去年
Johnson & Johnson Seeks European Approval to Expand AKEEGA for Metastatic Prostate Cancer with Genetic Alterations
2个月前
PARP Inhibitors Expand Beyond BRCA-Mutated Cancers: Emerging Evidence Across Solid Tumors and Combination Strategies
第 1 页，共 415 页
上一页
下一页
